Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NL-OMON20586Not yet recruiting
Open-label, single-arm trial of salbutamol in Dyspnoea (SOB), sponsored by University Medical Center Groningen. Primary endpoint: EMG measurements. Planned start Feb 2014; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NL-OMON20586.